海森药业：营收利润稳健增长，主营业务表现亮眼

Core Insights - The company reported a revenue of 242.09 million, representing a year-on-year growth of 14.93% [1] - The net profit attributable to shareholders reached 60.79 million, showing a year-on-year increase of 4.74% [1] - Significant growth was observed in the two core business segments, with the raw materials segment sales increasing by 13.94% and the intermediates segment sales surging by 29.24% [1] - The overall gross margin improved by 3.56 percentage points due to capacity optimization and the release of scale effects, indicating enhanced profitability [1] - The company's overall operations remain stable and show a positive trend [1]